A profitable company with steady sales. Institutions are adding.
Facts from SEC filings, not a recommendation.
From BNY's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
Last 12 months: $6.3B, up 26% from the 12 months before.
Move the sliders to your own view of BNY. Starting points are the company's recent numbers.
What today's price needs: with a 31% margin and a 17x P/E, sales could shrink about 5.1% a year for 5 years and still match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
Price chart by TradingView.
From annual reports filed with the SEC. Gross margin doesn't apply to banks and insurers, so it isn't scored. A checklist is a starting point for research, not a verdict.
Revenue and EPS as the company states them. Margins, cash flow and share count fill in with the 10-Q.
50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.
SEC filings of any kind. 50 means a normal week.
Institutions added 2.2% to their holdings. 862 bought, 784 sold.
| Insider | Trade | Shares | Avg price | Value | Owns after | Date |
|---|---|---|---|---|---|---|
Jose MinayaSenior Executive VP | Sell | 4K | $148.79 | $524K | 177K | Sep 28Filing ↗ |
| ||||||
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page